TILT Holdings (TLLTF) Income towards Parent Company (2021 - 2025)
TILT Holdings (TLLTF) reported Income towards Parent Company of -$2.9 million for Q2 2025, up 84.99% on a YoY basis from -$1.6 million in Q2 2024, and up 78.01% quarter-over-quarter from -$13.2 million in Q1 2025.
TILT Holdings (TLLTF) Income towards Parent Company (2021 - 2025) Analysis & Trends
TILT Holdings has reported Income towards Parent Company for 5 years, with the latest figure at -$2.9 million in Q2 2025.
- For the quarter ending Q2 2025, Income towards Parent Company rose 84.99% year-over-year to -$2.9 million; the trailing twelve-month figure through Jun 2025 stood at -$65.5 million (down 2.87% YoY), and the FY2024 full-year result was -$94.9 million, down 39.99% from the prior year.
- Income towards Parent Company for Q2 2025 stood at -$2.9 million, up from -$13.2 million in the prior quarter.
- The five-year high for Income towards Parent Company was $1.0 million in Q2 2021, with the low at -$71.6 million in Q4 2022.
- Historically, Income towards Parent Company has averaged -$16.8 million across 5 years, with a median of -$12.6 million in 2024.
- Annual changes were most pronounced in 2022 — Income towards Parent Company sank 1629.34% — and 2025, when it soared 84.99%.
- TILT Holdings' Income towards Parent Company stood at -$20.1 million in 2021, then tumbled by 255.85% to -$71.6 million in 2022, then jumped by 63.76% to -$26.0 million in 2023, then plunged by 41.37% to -$36.7 million in 2024, then jumped by 92.07% to -$2.9 million in 2025.
- The last three Income towards Parent Company figures came in at -$2.9 million (Q2 2025), -$13.2 million (Q1 2025), and -$36.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2.91 Mn |
| Mar 31, 2025 | -13.24 Mn |
| Dec 31, 2024 | -36.70 Mn |
| Sep 30, 2024 | -12.65 Mn |
| Jun 30, 2024 | -19.40 Mn |
| Mar 31, 2024 | -9.65 Mn |
| Dec 31, 2023 | -25.96 Mn |
| Sep 30, 2023 | -8.66 Mn |
| Jun 30, 2023 | -28.34 Mn |
| Mar 31, 2023 | -4.87 Mn |
| Dec 31, 2022 | -71.63 Mn |
| Sep 30, 2022 | -15.69 Mn |
| Jun 30, 2022 | -7.05 Mn |
| Mar 31, 2022 | -11.63 Mn |
| Dec 31, 2021 | -20.13 Mn |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 1.03 Mn |